Skip to main content
OpenTrials
Completed

NCT Number: NCT05916105

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use.

Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ciprofloxacin Adverse Reaction

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Rehab Hussein Werida

Damanhūr, Elbehairah, 31527, Egypt

About this study

From September 2021 to February 2022, a cross-sectional, research was undertaken to evaluate ciprofloxacin usage. The investigation was carried out by community pharmacists in seven Egyptian community pharmacies.

Data Collection: data gathered from pharmacy patients' records on a data collection form that included the factors indicated. The General Symptoms Questionnaire, physical examination, and blood testing were used to identify adverse occurrences.

Study variables:

  • age, gender, pregnancy/lactation
  • Department/indication
  • Dose, Frequency, Duration, Adverse events, Drug interactions.

Data was categorized and analyzed using appropriate software.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All ciprofloxacin included prescription during the study period.

Exclusion criteria

  • un included ciprofloxacin prescription.

Treatment and study plan

Ciprofloxacin Tablets

Drug

Ciprofloxacin antibiotic

Other names: Ciprofloxacin

Primary outcomes

  1. Indications

    Time frame: 6 months

    Appropriate Indications of ciprofloxacin (frequency )

  2. ciprofloxacin prescription (frequency )

    Time frame: 6 months

    Number of appropriate ciprofloxacin prescription

  3. adverse events

    Time frame: 6 months

    adverse events occured during ciprofloxacin therapy (frequency )

Sponsors and collaborators

Lead sponsor

Damanhour University

Other

Registry information

Official study title

Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jun 23, 2023
Registry last updated
Jun 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.